Atlas Trials

Study of AxoGuard® Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain

Clinical trial NCT03940963 · COMPLETED

Trial details

NCT number
NCT03940963
Sponsor
Axogen Corporation
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Symptomatic NeuromaMorton's NeuromaChronic Nerve Pain
Start date
2018-10-10
Primary completion
2023-07-17
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.